TTM
$3.75B
YoY change
+8.6%
5Y CAGR
-0.6%
Peak year (2021)
$4.21B
Cumulative gross profit
$76.06B
Gross Profit history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: $3.52B
Gross Profit growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: +8.6%
Gross Profit history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | $3.52B | +8.6% | +$279.00M | ||
| 2024 | $3.24B | +5.7% | +$175.00M | ||
| 2023 | $3.07B | -10.6% | −$364.00M | ||
| 2022 | $3.43B | -18.4% | −$776.00M | ||
| 2021 | $4.21B | +15.9% | +$576.00M | ||
| 2020 | $3.63B | +35.1% | +$944.00M | ||
| 2019 | $2.69B | +3.2% | +$84.00M | ||
| 2018 | $2.60B | -12.9% | −$385.00M | ||
| 2017 | $2.99B | +3.1% | +$91.00M | ||
| 2016 | $2.90B | +2.2% | +$63.00M | ||
| 2015 | $2.84B | +1.4% | +$38.00M | ||
| 2014 | $2.80B | -0.8% | −$22.00M | ||
| 2013 | $2.82B | -6.6% | −$197.90M | ||
| 2012 | $3.02B | -3.1% | −$97.30M | ||
| 2011 | $3.12B | +2.1% | +$63.50M | ||
| 2010 | $3.05B | -2.6% | −$82.00M | ||
| 2009 | $3.13B | +4.7% | +$140.40M | ||
| 2008 | $2.99B | +9.4% | +$258.24M | ||
| 2007 | $2.74B | +6.3% | +$162.41M | ||
| 2006 | $2.57B | +14.5% | +$326.28M | ||
| 2005 | $2.25B | +5.2% | +$110.49M | ||
| 2004 | $2.14B | +8.5% | +$166.55M | ||
| 2003 | $1.97B | +17.5% | +$293.67M | ||
| 2002 | $1.68B | +13.5% | +$199.49M | ||
| 2001 | $1.48B | +1.6% | +$22.62M | ||
| 2000 | $1.45B | +64.0% | +$567.36M | ||
| 1999 | $886.20M | +37.5% | +$241.50M | ||
| 1998 | $644.70M | -1.3% | −$8.50M | ||
| 1997 | $653.20M | +7.9% | +$47.78M | ||
| 1996 | $605.42M | — | — |
- 2025$3.52B+8.6%
- 2024$3.24B+5.7%
- 2023$3.07B-10.6%
- 2022$3.43B-18.4%
- 2021$4.21B+15.9%
- 2020$3.63B+35.1%
- 2019$2.69B+3.2%
- 2018$2.60B-12.9%
- 2017$2.99B+3.1%
- 2016$2.90B+2.2%
- 2015$2.84B+1.4%
- 2014$2.80B-0.8%
- 2013$2.82B-6.6%
- 2012$3.02B-3.1%
- 2011$3.12B+2.1%
- 2010$3.05B-2.6%
- 2009$3.13B+4.7%
- 2008$2.99B+9.4%
- 2007$2.74B+6.3%
- 2006$2.57B+14.5%
- 2005$2.25B+5.2%
- 2004$2.14B+8.5%
- 2003$1.97B+17.5%
- 2002$1.68B+13.5%
- 2001$1.48B+1.6%
- 2000$1.45B+64.0%
- 1999$886.20M+37.5%
- 1998$644.70M-1.3%
- 1997$653.20M+7.9%
- 1996$605.42M—
Gross Profit values are taken from Quest Diagnostics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current gross profit (TTM) is $3.75B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Quest Diagnostics (DGX) most recent annual gross profit stands at $3.52B (2025) – grew 8.6% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Quest Diagnostics gross profit compounded at -0.6% per year, sustaining 2 straight years of year-over-year growth.
Quest Diagnostics gross profit peaked at $4.21B in 2021; the latest annual figure is $3.52B in 2025 (16.3% below peak).
The highest annual gross profit of $4.21B was reported in 2021. The lowest in the available history was $605.42M in 1996.
Quest Diagnostics Gross Profit by Year
Quest Diagnostics Gross Profit 2025: $3.52B
Quest Diagnostics gross profit in 2025 was $3.52B, grew 8.6% from 2024.
Quest Diagnostics Gross Profit 2024: $3.24B
2024's gross profit for Quest Diagnostics came in at $3.24B, grew 5.7% from 2023.
Quest Diagnostics Gross Profit 2023: $3.07B
Quest Diagnostics posted gross profit of $3.07B in 2023, declined 10.6% below 2022.
Quest Diagnostics Gross Profit 2022: $3.43B
In 2022, Quest Diagnostics reported gross profit of $3.43B, declined 18.4% below 2021.
Quest Diagnostics Gross Profit 2021: $4.21B
Quest Diagnostics gross profit in 2021 was $4.21B.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Gross Profit
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $48.11B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B |
- $82.92B
- $68.56B
- $54.62B
- $48.11B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation